How PFAS May Affect the Thyroid
PFAS compounds structurally resemble thyroid hormones and may compete for binding sites on thyroid hormone transport proteins. Research suggests that PFAS can reduce available thyroxine (T4) and alter thyroid-stimulating hormone (TSH) levels through these displacement mechanisms. The thyroid gland regulates metabolism, growth, and development, making its disruption relevant to a wide range of health outcomes, particularly in pregnancy and early childhood.
Epidemiological Evidence
Multiple epidemiological studies have found associations between PFAS blood serum levels and altered thyroid hormone concentrations in adults. A significant body of research focuses on pregnant women, where thyroid disruption carries heightened risk for fetal brain development. Studies in occupationally exposed workers — including those in fluorochemical manufacturing — have found higher rates of hypothyroidism and elevated TSH. Population-level studies using NHANES data have identified associations even within the general population’s background PFAS exposure range.
Vulnerable Populations
Pregnant women face the most significant thyroid disruption risks from PFAS, as thyroid hormones drive fetal neurological development during the first trimester when the fetal thyroid is not yet functional. Neonates and young children are also considered vulnerable due to the importance of thyroid hormones in growth and development. Women with existing thyroid conditions may be particularly sensitive to PFAS disruption.
Implications for Drinking Water Protection
The thyroid disruption pathway provides one of several biological mechanisms linking PFAS exposure to adverse health outcomes. Reducing PFAS exposure through drinking water treatment — particularly for pregnant women and families with young children — is consistent with the precautionary approach recommended by endocrinologists and reproductive health specialists when reviewing the thyroid disruption literature.